v3.26.3
Shareholders' Equity - Changes in Shareholders' Equity (Details) - USD ($)
$ in Thousands
 3 Months Ended 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Sep. 30, 2026
Sep. 30, 2025
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance $ 1,514,680 $ 1,381,420 $ 1,504,134 $ 1,333,414
Beginning Balance (shares)     4,939,452  
Proceeds from exercise of stock options 2,018 222 $ 5,033 4,390
Proceeds from exercise of stock options (shares)     376,000  
Stock-based compensation expense 5,002 7,627 $ 17,691 19,621
Shares withheld for net settlements of share - based awards [1] (271) (2,254) (6,519) (24,431)
Reissuance of treasury shares [2]   (41,630) (86,734) (41,630)
Issuance of common stock - ESPP 38 40 119 127
Net income 49,203 173,922 134,969 222,538
Other comprehensive income (loss) 12 633 1,989 5,951
Ending Balance $ 1,570,682 1,519,980 $ 1,570,682 1,519,980
Ending Balance (shares) 10,097,801   10,097,801  
Common shares        
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance $ 1,424 $ 1,413 $ 1,412 $ 1,402
Beginning Balance (shares) 132,285,000 141,245,000 136,243,000 140,181,000
Proceeds from exercise of stock options $ 1   $ 4 $ 3
Proceeds from exercise of stock options (shares) 123,000 19,000 376,000 293,000
Restricted stock granted     $ 15 $ 18
Restricted stock granted (shares)     1,527,000 1,827,000
Restricted stock canceled     $ (2) $ (1)
Restricted stock canceled (shares) (31,000) (12,000) (198,000) (146,000)
Shares withheld for net settlements of share - based awards [1]   $ (1) $ (4) $ (10)
Shares withheld for net settlements of share-based awards (shares) [1] (9,000) (91,000) (426,000) (997,000)
Reissuance of treasury shares (shares) [2]   (1,967,000) (5,159,000) (1,967,000)
Issuance of common stock - ESPP (in shares) 1,000 2,000 6,000 5,000
Ending Balance $ 1,425 $ 1,412 $ 1,425 $ 1,412
Ending Balance (shares) 132,369,000 139,196,000 132,369,000 139,196,000
Additional Paid-In Capital        
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance $ 1,328,660 $ 1,309,317 $ 1,319,135 $ 1,315,256
Proceeds from exercise of stock options 2,017 222 5,029 4,387
Stock-based compensation expense 5,002 7,627 17,691 19,621
Restricted stock granted     (15) (18)
Restricted stock canceled     2 1
Shares withheld for net settlements of share - based awards [1] (271) (2,253) (6,515) (24,421)
Issuance of common stock - ESPP 38 40 119 127
Ending Balance 1,335,446 1,314,953 1,335,446 1,314,953
Retained Earnings (Accumulated Deficit)        
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance 380,089 88,546 294,252 39,880
Net income 49,214 173,940 135,051 222,606
Ending Balance 429,303 262,486 429,303 262,486
Accumulated Other Comprehensive Loss        
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance (15,983) (16,254) (17,972) (21,602)
Other comprehensive income (loss) 13 649 2,002 5,997
Ending Balance (15,970) (15,605) (15,970) (15,605)
Treasury shares        
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance $ (177,755) $ 0 $ (91,021) $ 0
Beginning Balance (shares) 10,098,000 0 4,939,000 0
Reissuance of treasury shares [2]   $ (41,630) $ (86,734) $ (41,630)
Reissuance of treasury shares (shares) [2]   1,967,000 5,159,000 1,967,000
Ending Balance $ (177,755) $ (41,630) $ (177,755) $ (41,630)
Ending Balance (shares) 10,098,000 1,967,000 10,098,000 1,967,000
Noncontrolling Interests        
Changes in shareholders' equity that are attributable to the Company's shareholders and to non controlling interests        
Beginning Balance $ (1,755) $ (1,602) $ (1,672) $ (1,522)
Net income (11) (18) (82) (68)
Other comprehensive income (loss) (1) (16) (13) (46)
Ending Balance $ (1,767) $ (1,636) $ (1,767) $ (1,636)
[1] The Company withheld shares through net settlements to satisfy statutory tax withholding requirements upon the vesting of shares

of restricted stock held by employees.
[2] During the nine months ended September 30, 2026 and 2025, the Company repurchased 5,158,349 and 1,966,779 shares of its

common stock in the open market, respectively